Loading…

Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates

The in vitro activity of levofloxacin and eight other antimicrobial agents against 60 clinical isolates of Stenotrophomonas maltophilia was determined by an agar dilution method using 10(4) and 10(6) cfu/spot inocula. At the lower inoculum, 85.0% of the isolates were susceptible to levofloxacin but...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 2000, Vol.45 (1), p.115-117
Main Authors: BONFIGLIO, G, CASCONE, C, AZZARELLI, C, CAFISO, V, MARCHETTI, F, STEFANI, S
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c440t-a1bf1423f7aff010865a3c73d683b7eb046c07cc605437d41d843e436cec6b203
cites
container_end_page 117
container_issue 1
container_start_page 115
container_title Journal of antimicrobial chemotherapy
container_volume 45
creator BONFIGLIO, G
CASCONE, C
AZZARELLI, C
CAFISO, V
MARCHETTI, F
STEFANI, S
description The in vitro activity of levofloxacin and eight other antimicrobial agents against 60 clinical isolates of Stenotrophomonas maltophilia was determined by an agar dilution method using 10(4) and 10(6) cfu/spot inocula. At the lower inoculum, 85.0% of the isolates were susceptible to levofloxacin but only 58.3% were susceptible to ofloxacin; at the higher inoculum, 78.3% were susceptible to levofloxacin and 36.7% to ofloxacin. In time-kill studies, levofloxacin exerted bactericidal activity within 4 h. With ofloxacin and ciprofloxacin bacterial regrowth was observed after 8 h. Levofloxacin may represent an alternative drug in the treatment of infections caused by S. maltophilia.
doi_str_mv 10.1093/jac/45.1.115
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70866763</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17483896</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-a1bf1423f7aff010865a3c73d683b7eb046c07cc605437d41d843e436cec6b203</originalsourceid><addsrcrecordid>eNqF0c9rFDEUB_AgFrtWb54liHhyti-TTDJzLMUfhYUequfwJpNg1kyyTjKL_e-N7ILiRQgkgQ9feO9LyCsGWwYDv96juRbdlm0Z656QDRMSmhYG9pRsgEPXKNHxS_I85z0AyE72z8glA9kO0LYb4nf2mFxIP9H4SOs5-rIkiqb4-nqkGCda_Gyb7z4Eao8YViw-RZocfSg2pqoP39KcImY6Yyj154NHaoKP3mCgPqeAxeYX5MJhyPbl-b4iXz9--HL7udndf7q7vdk1RggoDbLRMdFyp9A5YNDLDrlRfJI9H5UdQUgDyhgJneBqEmzqBbeCS2ONHFvgV-TdKfewpB-rzUXPPhsbAkab1qxVjZRK8v9CpkTP-0FW-OYfuE_rEusQumVKSs7UUNH7EzJLynmxTh8WP-PyqBno30XpWpQWnWa6FlX563PmOs52-gufmqng7Rlgrmt0C0bj8x_XSmAd8F-X2pwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217663179</pqid></control><display><type>article</type><title>Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates</title><source>Oxford University Press Journals</source><creator>BONFIGLIO, G ; CASCONE, C ; AZZARELLI, C ; CAFISO, V ; MARCHETTI, F ; STEFANI, S</creator><creatorcontrib>BONFIGLIO, G ; CASCONE, C ; AZZARELLI, C ; CAFISO, V ; MARCHETTI, F ; STEFANI, S</creatorcontrib><description>The in vitro activity of levofloxacin and eight other antimicrobial agents against 60 clinical isolates of Stenotrophomonas maltophilia was determined by an agar dilution method using 10(4) and 10(6) cfu/spot inocula. At the lower inoculum, 85.0% of the isolates were susceptible to levofloxacin but only 58.3% were susceptible to ofloxacin; at the higher inoculum, 78.3% were susceptible to levofloxacin and 36.7% to ofloxacin. In time-kill studies, levofloxacin exerted bactericidal activity within 4 h. With ofloxacin and ciprofloxacin bacterial regrowth was observed after 8 h. Levofloxacin may represent an alternative drug in the treatment of infections caused by S. maltophilia.</description><identifier>ISSN: 0305-7453</identifier><identifier>ISSN: 1460-2091</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/45.1.115</identifier><identifier>PMID: 10629022</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Anti-Infective Agents - pharmacology ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Humans ; Levofloxacin ; Medical sciences ; Microbial Sensitivity Tests ; Ofloxacin - pharmacology ; Pharmacology. Drug treatments ; Stenotrophomonas maltophilia ; Stenotrophomonas maltophilia - drug effects ; Time Factors</subject><ispartof>Journal of antimicrobial chemotherapy, 2000, Vol.45 (1), p.115-117</ispartof><rights>2000 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Jan 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-a1bf1423f7aff010865a3c73d683b7eb046c07cc605437d41d843e436cec6b203</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,4043,27956,27957,27958</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1260150$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10629022$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BONFIGLIO, G</creatorcontrib><creatorcontrib>CASCONE, C</creatorcontrib><creatorcontrib>AZZARELLI, C</creatorcontrib><creatorcontrib>CAFISO, V</creatorcontrib><creatorcontrib>MARCHETTI, F</creatorcontrib><creatorcontrib>STEFANI, S</creatorcontrib><title>Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>The in vitro activity of levofloxacin and eight other antimicrobial agents against 60 clinical isolates of Stenotrophomonas maltophilia was determined by an agar dilution method using 10(4) and 10(6) cfu/spot inocula. At the lower inoculum, 85.0% of the isolates were susceptible to levofloxacin but only 58.3% were susceptible to ofloxacin; at the higher inoculum, 78.3% were susceptible to levofloxacin and 36.7% to ofloxacin. In time-kill studies, levofloxacin exerted bactericidal activity within 4 h. With ofloxacin and ciprofloxacin bacterial regrowth was observed after 8 h. Levofloxacin may represent an alternative drug in the treatment of infections caused by S. maltophilia.</description><subject>Anti-Infective Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Humans</subject><subject>Levofloxacin</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Ofloxacin - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Stenotrophomonas maltophilia</subject><subject>Stenotrophomonas maltophilia - drug effects</subject><subject>Time Factors</subject><issn>0305-7453</issn><issn>1460-2091</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqF0c9rFDEUB_AgFrtWb54liHhyti-TTDJzLMUfhYUequfwJpNg1kyyTjKL_e-N7ILiRQgkgQ9feO9LyCsGWwYDv96juRbdlm0Z656QDRMSmhYG9pRsgEPXKNHxS_I85z0AyE72z8glA9kO0LYb4nf2mFxIP9H4SOs5-rIkiqb4-nqkGCda_Gyb7z4Eao8YViw-RZocfSg2pqoP39KcImY6Yyj154NHaoKP3mCgPqeAxeYX5MJhyPbl-b4iXz9--HL7udndf7q7vdk1RggoDbLRMdFyp9A5YNDLDrlRfJI9H5UdQUgDyhgJneBqEmzqBbeCS2ONHFvgV-TdKfewpB-rzUXPPhsbAkab1qxVjZRK8v9CpkTP-0FW-OYfuE_rEusQumVKSs7UUNH7EzJLynmxTh8WP-PyqBno30XpWpQWnWa6FlX563PmOs52-gufmqng7Rlgrmt0C0bj8x_XSmAd8F-X2pwA</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>BONFIGLIO, G</creator><creator>CASCONE, C</creator><creator>AZZARELLI, C</creator><creator>CAFISO, V</creator><creator>MARCHETTI, F</creator><creator>STEFANI, S</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>2000</creationdate><title>Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates</title><author>BONFIGLIO, G ; CASCONE, C ; AZZARELLI, C ; CAFISO, V ; MARCHETTI, F ; STEFANI, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-a1bf1423f7aff010865a3c73d683b7eb046c07cc605437d41d843e436cec6b203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Anti-Infective Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Humans</topic><topic>Levofloxacin</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Ofloxacin - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Stenotrophomonas maltophilia</topic><topic>Stenotrophomonas maltophilia - drug effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BONFIGLIO, G</creatorcontrib><creatorcontrib>CASCONE, C</creatorcontrib><creatorcontrib>AZZARELLI, C</creatorcontrib><creatorcontrib>CAFISO, V</creatorcontrib><creatorcontrib>MARCHETTI, F</creatorcontrib><creatorcontrib>STEFANI, S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BONFIGLIO, G</au><au>CASCONE, C</au><au>AZZARELLI, C</au><au>CAFISO, V</au><au>MARCHETTI, F</au><au>STEFANI, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>2000</date><risdate>2000</risdate><volume>45</volume><issue>1</issue><spage>115</spage><epage>117</epage><pages>115-117</pages><issn>0305-7453</issn><issn>1460-2091</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-1</notes><notes>content type line 23</notes><notes>ObjectType-Article-1</notes><notes>ObjectType-Feature-2</notes><abstract>The in vitro activity of levofloxacin and eight other antimicrobial agents against 60 clinical isolates of Stenotrophomonas maltophilia was determined by an agar dilution method using 10(4) and 10(6) cfu/spot inocula. At the lower inoculum, 85.0% of the isolates were susceptible to levofloxacin but only 58.3% were susceptible to ofloxacin; at the higher inoculum, 78.3% were susceptible to levofloxacin and 36.7% to ofloxacin. In time-kill studies, levofloxacin exerted bactericidal activity within 4 h. With ofloxacin and ciprofloxacin bacterial regrowth was observed after 8 h. Levofloxacin may represent an alternative drug in the treatment of infections caused by S. maltophilia.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>10629022</pmid><doi>10.1093/jac/45.1.115</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 2000, Vol.45 (1), p.115-117
issn 0305-7453
1460-2091
1460-2091
language eng
recordid cdi_proquest_miscellaneous_70866763
source Oxford University Press Journals
subjects Anti-Infective Agents - pharmacology
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Biological and medical sciences
Humans
Levofloxacin
Medical sciences
Microbial Sensitivity Tests
Ofloxacin - pharmacology
Pharmacology. Drug treatments
Stenotrophomonas maltophilia
Stenotrophomonas maltophilia - drug effects
Time Factors
title Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T20%3A18%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Levofloxacin%20in%20vitro%20activity%20and%20time-kill%20evaluation%20of%20Stenotrophomonas%20maltophilia%20clinical%20isolates&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=BONFIGLIO,%20G&rft.date=2000&rft.volume=45&rft.issue=1&rft.spage=115&rft.epage=117&rft.pages=115-117&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/45.1.115&rft_dat=%3Cproquest_cross%3E17483896%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c440t-a1bf1423f7aff010865a3c73d683b7eb046c07cc605437d41d843e436cec6b203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=217663179&rft_id=info:pmid/10629022&rfr_iscdi=true